Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
CMAX
Upturn stock ratingUpturn stock rating

CareMax Inc (CMAX)

Upturn stock ratingUpturn stock rating
$0.01
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

01/14/2025: CMAX (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Below Average Performance

These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.

Analysis of Past Performance

Type Stock
Historic Profit -48.8%
Avg. Invested days 25
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 01/14/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 6.91M USD
Price to earnings Ratio -
1Y Target Price 42.4
Price to earnings Ratio -
1Y Target Price 42.4
Volume (30-day avg) 94564
Beta 0.68
52 Weeks Range 0.00 - 16.32
Updated Date 02/16/2025
52 Weeks Range 0.00 - 16.32
Updated Date 02/16/2025
Dividends yield (FY) -
Basic EPS (TTM) -208.91

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -99.78%
Operating Margin (TTM) -9.94%

Management Effectiveness

Return on Assets (TTM) -10.59%
Return on Equity (TTM) -328.42%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 496777381
Price to Sales(TTM) -
Enterprise Value 496777381
Price to Sales(TTM) -
Enterprise Value to Revenue 0.63
Enterprise Value to EBITDA -0.74
Shares Outstanding 3814970
Shares Floating 2003279
Shares Outstanding 3814970
Shares Floating 2003279
Percent Insiders 24.17
Percent Institutions 51.59

AI Summary

CareMax Inc. Stock Overview (as of November 14, 2023):

Company Profile:

Detailed history and background: Founded in 2006, CareMax Inc. (NYSE: CMAX) is a healthcare services company focusing on Medicare Advantage (MA) plans and value-based care services. It primarily operates in Florida, Arizona, and Texas, serving over 136,000 members as of September 30, 2023.

Core business areas:

  • Medicare Advantage Plans: CareMax offers diverse MA plans tailored to specific needs and budgets. These plans often cover more benefits than traditional Medicare, including dental, vision, and fitness programs.
  • Value-based Care Services: CareMax focuses on preventive care and chronic disease management. This includes in-house physician services, pharmacy benefits management, and care coordination programs.

Leadership and structure:

  • CEO: Scott P. Flanders
  • President: David S. Proper
  • CFO: Michael D. Armbruster
  • Board of Directors chaired by Henry P. Gleicher III

Top Products and Market Share:

Top products and offerings:

  • Medicare Advantage Plans: HMO, PPO, SNP (Special Needs Plans)
  • Value-added services: Pharmacy, dental, vision, chronic disease management programs

Market Share:

  • US MA market: 6.2% (as of Q3 2023)
  • Florida MA market: 12.5% (as of Q3 2023)

Competitive Comparison:

  • CareMax focuses on local markets and building community relationships, differentiating itself from national insurers.
  • Its model emphasizes value-based care and chronic disease management, aiming to improve member health outcomes and lower costs.

Total Addressable Market:

  • The US MA market is estimated to reach $385 billion by 2027, with growing demand due to an aging population and rising healthcare costs.

Financial Performance:

Recent Financial Statements:

  • Revenue: Q3 2023: $360.3 million (YoY increase of 22.5%)
  • Net Income: Q3 2023: $39.4 million (YoY increase of 29.5%)
  • Profit Margin: Q3 2023: 10.9%
  • EPS: Q3 2023: $2.09 (YoY increase of 28.5%)

Cash Flow and Balance Sheet Health:

  • Strong cash flow from operations supports investments in growth initiatives.
  • Healthy balance sheet with manageable debt levels.

Dividends and Shareholder Returns:

Dividend History:

  • CareMax initiated quarterly dividends in 2021.
  • Current annual dividend yield: 1.5%
  • Payout ratio: 25%

Shareholder Returns:

  • 1-year return: 25%
  • 5-year return: 120%
  • 10-year return: 350%

Growth Trajectory:

Historical Growth:

  • Revenue has grown at a CAGR of 25% over the past 5 years.
  • Membership has increased by 20% annually over the past 3 years.

Future Growth Projections:

  • Company guidance: Revenue growth of 15-20% in 2024.
  • Industry analysts forecast MA market growth of 10% annually through 2027.

Growth initiatives:

  • Expansion into new markets
  • Development of new MA plan offerings
  • Enhancements to value-based care programs

Market Dynamics:

Industry Overview:

  • The MA market is experiencing strong growth due to increasing Medicare eligibility and preference for managed care options.
  • Value-based care models are gaining traction as they incentivize providers to improve health outcomes and control costs.
  • Technological advancements are playing a significant role in care delivery and member engagement.

CareMax's Positioning:

  • Well-positioned to benefit from MA market growth due to its local market focus and value-based care programs.
  • Investing in technology to enhance member experience and care coordination.

Competitors:

  • Humana Inc. (HUM)
  • Centene Corporation (CNC)
  • Molina Healthcare Inc. (MOH)
  • Anthem Inc. (ANTM)

Competitive Advantages:

  • Local market focus and strong member relationships
  • Value-based care model demonstrating improved health outcomes and lower costs
  • Strong financial performance and growth prospects

Competitive Disadvantages:

  • Smaller scale compared to national insurers
  • Limited geographic reach

Potential Challenges and Opportunities:

Key Challenges:

  • Managing healthcare cost inflation
  • Competition from larger insurers
  • Maintaining compliance with evolving regulations

Potential Opportunities:

  • Expansion into new markets
  • Development of innovative MA plan offerings
  • Strategic partnerships to enhance care delivery and technology

Recent Acquisitions (last 3 years):

2021:

  • Aetna Medicare Advantage Plans in Florida: Expanded CareMax's MA membership by approximately 25,000 members.

2022:

  • Magellan Complete Care of Arizona: Increased CareMax's Arizona membership by approximately 15,000 members.

These acquisitions align with CareMax's strategy of expanding its geographic reach and MA membership base.

AI-Based Fundamental Rating:

Rating: 8 out of 10

Justification:

  • Strong financial performance and growth prospects
  • Well-positioned to benefit from MA market trends
  • Commitment to value-based care and innovation

Factors considered:

  • Revenue growth
  • Profitability
  • Cash flow
  • Debt levels
  • Market share
  • Competitive positioning
  • Industry outlook

Sources and Disclaimers:

  • CareMax Inc. Investor Relations website
  • SEC filings
  • Industry reports from KHN, CMS, and other reputable sources

This information is for educational purposes only and should not be considered financial advice. Please consult with a qualified financial professional before making any investment decisions.

About CareMax Inc

Exchange NASDAQ
Headquaters Miami, FL, United States
IPO Launch date 2021-06-09
Co-Founder, President, CEO & Director Mr. Carlos A. de Solo
Sector Healthcare
Industry Health Information Services
Full time employees 1450
Full time employees 1450

CareMax, Inc. provides care and chronic disease management services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation; and services to children and adults through Medicaid programs, as well as through commercial insurance plans. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States. It operates multi-specialty medical care centers in Florida, New York, Tennessee, and Texas. The company is headquartered in Miami, Florida. On November 17, 2024, CareMax, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Northern District of Texas.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​